Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer

PURPOSE: The aim of the study was to evaluate the efficacy and safety of stereotactic body radiotherapy (SBRT) for pulmonary lesions in oligometastatic non‐small cell lung cancer (NSCLC) patients, to explore prognostic factors of progression‐free survival (PFS) and overall survival (OS), to validate...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Wen, Yu, Jing, Nuerjiang, Shuake, Li, Zhijun, Wang, Dajiang, Wang, Xiaoyong, Zhang, Junhong, Xie, Conghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712475/
https://www.ncbi.nlm.nih.gov/pubmed/31245933
http://dx.doi.org/10.1002/cam4.2366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712475/
https://www.ncbi.nlm.nih.gov/pubmed/31245933
http://dx.doi.org/10.1002/cam4.2366

Ejemplares similares